Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.60 |
| ▸ | CA12 | O43570 | 5/20 | 0.60 |
| ▸ | CA9 | Q16790 | 5/20 | 0.60 |
| ▸ | CA1 | P00915 | 2/20 | 0.60 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.54 |
| ▸ | TYR | P14679 | 1/20 | 0.54 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.54 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | MAPT | P10636 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.49 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14354286 | 1.00 | CA2 (0.60) | CA2CA12CA9CA1TRIM24 | |
| SCHEMBL14353941 | 1.00 | CA2 (0.60) | CA2CA12CA9CA1TRIM24 | |
| SCHEMBL14353869 | 1.00 | CA2 (0.60) | CA2CA12CA9CA1TRIM24 | |
| SCHEMBL14353866 | 1.00 | CA2 (0.60) | CA2CA12CA9CA1TRIM24 | |
| SCHEMBL14354411 | 1.00 | CA2 (0.60) | CA2CA12CA9CA1TRIM24 | |
| SCHEMBL14354410 | 1.00 | CA2 (0.60) | CA2CA12CA9CA1TRIM24 | |
| SCHEMBL14353939 | 1.00 | CA2 (0.60) | CA2CA12CA9CA1TRIM24 | |
| SCHEMBL14353937 | 0.93 | CA2 (0.57) | CA2CA12CA9CA1TRIM24 | |
| SCHEMBL14353935 | 0.93 | CA2 (0.57) | CA2CA12CA9CA1TRIM24 | |
| SCHEMBL17743543 | 0.92 | CA2 (0.64) | CA2CA12CA9CA1TRIM24 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9187510-B2 | Light-emitting organic platinum complex, light-emitting material containing this complex and functional device | OSAKA UNIVERSITY (JP) | 2015-11-17 | — | — | US | disclosed |
| US-20130001535-A1 | LIGHT-EMITTING ORGANIC PLATINUM COMPLEX, LIGHT-EMITTING MATERIAL CONTAINING THIS COMPLEX AND FUNCTIONAL DEVICE | OSAKA UNIVERSITY (JP) | 2013-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130001535-A1 | LIGHT-EMITTING ORGANIC PLATINUM COMPLEX, LIGHT-EMITTING MATERIAL CONTAINING THIS COMPLEX AND FUNCTIONAL DEVICE | CRY2, C9, PMS2 | CA2 1724/4885CA12 195/4885CA9 2096/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.